Thank you for the question. It gives me a chance to put my view of the situation on the record.
I've been criss-crossing the country, as has Gary Goodyear, talking to university presidents, researchers, people on the front lines of some of the very research that you mentioned. To a person they have said that our government is doing the right thing, that we ought not to listen to all of this barking and complaining, which doesn't represent how scientists and organizers of scientists feel about the situation. They've told us they know we are putting more in than ever before, more into the granting councils, and more in multi-year funding for Genome Canada.
This time last year, I was in San Diego, announcing a multi-million-dollar collaboration with the California government on cancer stem-cell research. We are the best in the world in this field, and that's multi-year funding. What they are telling us, what they're telling the Prime Minister, what they're telling their own confrères is that this government is putting the money in, and that we're doing it in a sensible way that will have a long-term positive impact on our ability to compete.
The STIC report came out today. I encourage you to read it. This is the Science, Technology and Innovation Council report, which said we were doing a great job in innovation and basic research. Our problem is commercialization, which is the exact antithesis of the editorial position of the Globe and Mail. I'm sorry, but if I have to choose between the two, I think the Science, Technology and Innovation Council probably has it right.
Since 2007, our government and the S and T strategy has said that this is the area where we have to do better. We have to make sure that all the wonderful basic research that we do actually gets to market, actually helps our health care sector, our businesses, and our innovators, the RIMs of tomorrow. That's what I passionately believe in. I know you have your impression; I just think it's wrong.